Edition:
United States

Apricus Biosciences Inc (APRI.OQ)

APRI.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
26 May 2017
Change (% chg)

$-0.01 (-1.04%)
Prev Close
$0.96
Open
$0.93
Day's High
$0.99
Day's Low
$0.91
Volume
15,902
Avg. Vol
162,430
52-wk High
$5.95
52-wk Low
$0.88

Latest Key Developments (Source: Significant Developments)

Apricus Biosciences Q1 earnings per share $1.04
Thursday, 11 May 2017 04:01pm EDT 

May 11 (Reuters) - Apricus Biosciences Inc ::Apricus Biosciences provides corporate update and first quarter 2017 financial results.Q1 earnings per share $1.04.Apricus Biosciences Inc says Vitaros U.S. NDA re-submission remains on track for q3 2017.Apricus Biosciences Inc says vitaros drug-device human factor studies underway.Apricus Biosciences Inc says operations funded through Q3 of 2018.  Full Article

Apricus Biosciences reports initiation of vitaros drug-device human factors study
Thursday, 4 May 2017 07:00am EDT 

May 4 (Reuters) - Apricus Biosciences Inc :Apricus Biosciences announces the initiation of vitaros drug-device human factors study.Apricus biosciences inc- vitaros drug-device combination human factor testing study required by food and drug administration is underway.Apricus biosciences - expect study will be completed in q2 of this year and results will be incorporated into our planned vitaros nda re-submission.Apricus biosciences inc- vitaros nda re-submission remains on track for q3 of this year.  Full Article

Apricus Biosciences announces pricing of $7.0 mln public offering
Friday, 21 Apr 2017 06:00am EDT 

April 21 (Reuters) - Apricus Biosciences Inc :Apricus Biosciences announces pricing of $7.0 million public offering.Apricus Biosciences Inc - pricing of an underwritten public offering of an aggregate of 5.03 million units.Apricus Biosciences Inc says pricing of an underwritten public offering of an aggregate of 5 million units at public offering price of $1.40 per unit.  Full Article

Apricus Biosciences files for offering of up to $6.0 mln of units
Monday, 17 Apr 2017 07:52am EDT 

April 17 (Reuters) - Apricus Biosciences Inc :Files for offering of up to $6.0 million of units, consisting of one share of common stock,warrant to purchase 0.75 of common share.  Full Article

Apricus Biosciences files for offering of up to $6.9 mln shares - SEC filing
Thursday, 30 Mar 2017 04:28pm EDT 

Apricus Biosciences Inc :Files for offering of up to $6.9 million of co's common stock - SEC filing.  Full Article

Apricus Biosciences Q4 loss per share $0.04
Monday, 13 Mar 2017 04:13pm EDT 

Apricus Biosciences Inc : Apricus biosciences provides corporate update, fourth quarter and full year 2016 financial results . Q4 loss per share $0.04 . Apricus biosciences inc says vitaros u.s. Nda re-submission on track for q3 2017 .Q4 revenue $400,000.  Full Article

Apricus Biosciences announces sale of ex-U.S. Vitaros assets, rights to Ferring Pharmaceuticals
Wednesday, 8 Mar 2017 04:01pm EST 

Apricus Biosciences Inc : Apricus biosciences announces sale of ex-u.s. Vitaros assets and rights to ferring pharmaceuticals . Apricus biosciences inc - apricus will retain its vitaros rights in u.s. . Apricus biosciences inc - remains on track to re-submit vitaros nda to fda in q3 of 2017 . Says ferring has agreed to pay apricus an upfront payment of $11.5 million .Says ferring has aso agreed to pay apricus up to an additional $700,000 with respect to certain product inventory.  Full Article

Apricus Biosciences and certain investors mutually agreed to terminate certain securities purchase agreement
Wednesday, 28 Sep 2016 08:37am EDT 

Apricus Biosciences Inc : On Sept 27, co and certain investors mutually agreed to terminate certain securities purchase agreement, dated Sept 22 . Entered into a new securities purchase agreement for sale by co of 13.1 million shares of co's common stock, par value $0.001per share .Net proceeds are expected to be approximately $4.2 million and will be used for general corporate and working capital purposes.  Full Article

Apricus Biosciences to issue about 13.1 mln shares at $0.35 per share
Friday, 23 Sep 2016 08:00am EDT 

Apricus Biosciences Inc [APRI.O] : Apricus Biosciences announces $4.6 million registered direct offering .In connection with offering, will issue about 13.1 million registered shares of common stock at a purchase price of $0.35 per share.  Full Article

Apricus Biosciences says gets $4.5 mln in upfront payments from Ferring
Monday, 15 Aug 2016 07:00am EDT 

Apricus Biosciences Inc : Company's partner in United Kingdom, has received United Kingdom marketing authorization for Vitaros .Under terms of agreement, Apricus has received a total of $4.5 million in upfront payments from Ferring.  Full Article

More From Around the Web

BRIEF-Apricus Biosciences reports initiation of vitaros drug-device human factors study

* Apricus Biosciences announces the initiation of vitaros drug-device human factors study